The Company's ordinary shares are listed on AIM, a market operated by the London Stock Exchange, under the symbol “AREC”. The Company is not listed on any other exchanges or trading platforms.

View

Arecor Therapeutics Notice of AGM

27 April 2022

View

Arecor Therapeutics Form of Proxy

27 April 2022

Major shareholders

BGF Investment Management Limited

13.21%

Unilever*

9.61%

Calculus Funds*

8.17%

Downing LLP*

5.69%

Lombard Odier Asset Management (Europe) Limited

5.32%

Oxford Technology 2 VCT plc

5.21%

Albion Capital Funds*

5.03%

Stewart Newton

4.74%

Chelverton Asset Management

4.67%

The Wood family

3.99%

Unicorn AIM VCT

3.93%

Sarah Howell

2.78%

Amati AIM VCT

2.77%

The number of shares in issue: 30,486,750
Percentage of shares not in public hands: c. 65.8%
Last reviewed and updated: 18 August 2022

* Total numbers are the aggregate amounts held

* Total numbers are the aggregate amounts held by different Unilever entities

Constitutional Documents

Date Title View

2 June 2021

Articles of Association

1 June 2021

Admission Document